Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Renal anaemia is caused by a relative erythropoietin (EPO) deficiency. Due to difficult interpretation of serum EPO concentrations adapted to anaemia and renal function, the diagnostic value of measuring serum EPO concentrations is limited. METHODS: We retrospectively analysed the relationship between haemoglobin and serum EPO concentrations routinely measured in in- and out-patients of our university hospital from 2001-04. Patients under EPO substitution or those with acute renal failure, polycystic kidney disease, renal carcinoma or polycythaemia due to pulmonary disease were excluded. The study population (n = 500) was then stratified according to the presence or absence of chronic kidney disease (CKD) and to the stage if CKD was present. EPO concentrations were expressed in percentiles corrected for the severity of anaemia and based on the EPO response in patients without CKD. RESULTS: In patients without CKD (n = 167) there was a strong parametric correlation between severity of anaemia and increase in EPO (r = -0.81). Linear regression of the log-transformed EPO values revealed the equation log EPO (mIU/ml) = -0.135 x Hb (g/dl) + 2.821 (r(2) = 0.65). With increasing stages of CKD the correlation between haemoglobin and EPO concentrations was gradually attenuated and was completely lost in CKD stage four and five. In anaemic patients with Hb < 11 g/dl, relative EPO deficiency defined as EPO concentrations below the 25th percentile was present in 38%, 67%, 93% and 100% of the patients with CKD stages 1-5, respectively. CONCLUSIONS: Expression of EPO concentrations in percentiles improves the diagnostic value of measuring EPO concentrations for diagnosing relative EPO deficiency and renal anaemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While hepatic HAMP formation is increased during inflammation, EPO production in the kidney is subject to inhibition by inflammatory mediators such as tumor necrosis factor (TNF) and IL-1 [82–84].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [84]
Citations
Cites
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Levey, A. S., Coresh, J., Greene, T., Marsh, J., Stevens, L. A., Kusek, J. W., Van Lente, F., & for Chronic Kidney Disease Epidemiology Collaboration (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.077180 · Cited by 1,855 · cited 1×
“according to the IDMS-corrected simplified MDRD formula [9] whereby MDRD–GFR1⁄4 175 serum creatinine (mg/dl) 1.”
MethodHenke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250 · cited 1×
“However, it remains unclear whether tumour response and overall survival are also affected [24,25].”
BackgroundErythropoietin: Physiology and Pharmacology Update
Fisher, J. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800101 · Cited by 708
Decreased Erythropoietin Response in Patients with the Anemia of Cancer
Miller, C. B., Jones, R. J., Piantadosi, S., Abeloff, M. D., & Spivak, J. L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006143222401 · Cited by 658 · cited 1×
“This had been previously shown for patients with various tumours [22] or rheumatoid arthritis [23].”
BackgroundErythropoietin or darbepoetin for patients with cancer
Tonia, T., Mettler, A., Robert, N., Schwarzer, G., Seidenfeld, J., Weingart, O., Hyde, C., Engert, A., & Bohlius, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003407.pub5 · Cited by 392
OBRADOR, G. T., RUTHAZER, R., ARORA, P., KAUSZ, A. T., & PEREIRA, B. J. G. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1081793 · Cited by 244
Anemia induces accumulation of erythropoietin mRNA in the kidney and liver.
Bondurant, M. C., & Koury, M. J. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.7.2731 · Cited by 242 · cited 1×
“This might be attributable to residual renal function or alternatively hepatic production [14,15].”
BackgroundBeguin, Y., Clemons, G., Pootrakul, P., & Fillet, G. (1993) · Blood · doi:10.1182/blood.v81.4.1067.1067 · Cited by 227
Anemia: An early complication of chronic renal insufficiency
Kazmi, W. H., Kausz, A. T., Khan, S., Abichandani, R., Ruthazer, R., Obrador, G. T., & Pereira, B. J. G. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27699 · Cited by 222 · cited 1×
“Renal anaemia is a common and early complication in chronic kidney disease (CKD) and is found in nearly all patients with severe renal failure [1,2].”
Background
Cited by
Tirichen, H., Yaigoub, H., Xu, W., Wu, C., Li, R., & Li, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.627837 · Cited by 407
2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
Tsubakihara, Y., Nishi, S., Akiba, T., Hirakata, H., Iseki, K., Kubota, M., Kuriyama, S., Komatsu, Y., Suzuki, M., Nakai, S., et al. (2010) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2010.00836.x · Cited by 278
The multifaceted role of iron in renal health and disease
van Swelm, R. P. L., Wetzels, J. F. M., & Swinkels, D. W. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0197-5 · Cited by 275
2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease
Yamamoto, H., Nishi, S., Tomo, T., Masakane, I., Saito, K., Nangaku, M., Hattori, M., Suzuki, T., Morita, S., Ashida, A., et al. (2017) · Renal Replacement Therapy · doi:10.1186/s41100-017-0114-y · Cited by 252
“Serum EPO level is maintained within the reference range regardless of Hb level in most CKD patients [5, 6].”
BackgroundResultInfluentialWilliams, A. W., Dwyer, A. C., Eddy, A. A., Fink, J. C., Jaber, B. L., Linas, S. L., Michael, B., O’Hare, A. M., Schaefer, H. M., Shaffer, R. N., et al. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04970512 · Cited by 182
“Serum erythropoietin deficiency is often relative and, in advanced CKD, usually does not correlate with the degree of anemia (84,85).”
Background
Metadata
- Authors
- Artunc, F., & Risler, T.
- Affiliations
- University of Tübingen (DE)
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-07
- Volume
- 22
- Issue
- 10
- Pages
- 2900-2908
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2152233370
- Cited by
- 116
- References
- 23
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 10 · 2022: 2 · 2021: 13 · 2020: 4 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 12 · 2015: 6 · 2014: 7 · 2013: 3 · 2012: 3
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nephrology Dialysis Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medac
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- erythropoietin, anemia of chronic kidney disease, chronic kidney disease, hemoglobin, anemia severity, CKD stage
- MeSH terms
- Adult, Aged, Anemia, Chemistry, Clinical, Erythropoietin, Female, Hemoglobins, Humans, Kidney Failure, Chronic, Polycystic Kidney Diseases, Male, Middle Aged, Models, Biological, Regression Analysis, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. https://app.cochat.ai/papers/10.1093/ndt/gfm316
- The paper
- Artunc, F., & Risler, T. (2007). Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfm316
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.